Skip Navigation

Technology Development

Office of Research

Office of Research

Radiofluorination and Radiopharmaceuticals for PET Imaging

Disclosure #: 1019,1020,1023,1041
Description: The total market for diagnostic radiopharmaceuticals, such as 18F-labeled compounds used for PET imaging, was worth $1.2 billion in 2007 and will reach $3.3 billion by 2013, driven in part by the introduction of novel compounds with increased specificity (Source) The short half-life of 18F and harsh reaction conditions used for fluorination limit the scope of fluorinated radiotracers that can be easily prepared. Dr. Stephen DiMagno and his team at the University of Nebraska–Lincoln have developed highly reactive 18F sources that reduce reaction time, allowing a wide range of new compounds to be produced with high radioactivity. Radiotracer synthesis can be coupled with a novel, highly sensitive assay for radiochemical purity.
Advantage(s):
  • High-speed, highly efficient method to produce radiofluorinated compounds
  • Fast reaction time and mild reaction conditions expand the range of biologically relevant compounds that can be fluorinated
  • Suitable for preparation of radiopharmaceuticals that cannot be easily made through conventional means, such as 18F-labeled electron-rich aromatic compounds (e.g., 18F-L-DOPA)
  • Short reaction time limits isotope decay, leading to higher-quality PET images
  • Much more cost effective that current methods for radiofluorination
  • A rapid (15-min), highly sensitive (sub-picogram) assay allows detection of background contamination by non-radioactive anions prior to radiotracer synthesis
Application(s):
  • Preparation of radiopharmaceuticals for clinical diagnosis of neurological conditions, cancer, cardiovascular disease, and other conditions
  • Production of 18F-labeled drug analogues to study drug behavior in the body
Publication(s):
Licensing Manager: Dr. Jane Garrity
jgarrity@nutechventures.org
(402) 472-1782
Inventor(s): Stephen DiMagno
Technology Brief: Marketing Brief- Radiofluorination and Radiopharmaceuticals for PET Imaging.pdf
Supporting Document(s): Application # 11 778349.pdf
Application # 11 226277.pdf
PCT US2007 073623.pdf


Back